JMI Laboratories   Report issue

For profit Phase 3
Founded: North Liberty IA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2015
NCT02651428
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

citric acid (1 trial)

heparin (liquaemin) (1 trial)

taurolidine (Defencath) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Catheter-Related Infections (Phase 3)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Kidney Failure, Chronic (Phase 3)

Renal Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3